Routine follow-up in patients treated of head and neck cancer
Journal Title: Otolaryngologia Polska - Year 2012, Vol 66, Issue 2
Abstract
SUMMARY Objective: to evaluate the usefulness of routine follow-up in group of patients with head and neck cancer and to present the recommended schedule taking into consideration the oncological safety and costefectivness. Aim: retrospective cohort study with follow-up of 3 years for all patients. Results: In Outpatient Department in 2010 there were examined 3012 patients treated of head and neck cancer. The biggest group comprised patients with larynx and oral cavity cancer. During routine ENT examination 70% of recurrences was detected. Conclusion: In patients with head and neck cancer routine follow up is indispensable. Introduced modern schedules make the monitoring work-up shorter and more sensible, although the benefit in improving patients survival is doubtful.
Authors and Affiliations
Małgorzata Wierzbicka, Elżbieta Waśniewska, Joanna Jackowska, Witold Szyfter
Sprawozdanie z Międzynarodowej Konferencji nt “Improving Outcomes for children with hearing loss: challenges and solutions”
Early hearing evaluation in patients treated by surgery due to chronic otitis
Intoduction. The aim of the study was the comparison of hearing before and after ear surgery in patients with chronic otitis media according to Fowler and Sabine criteria. Material. The study comprised 42 patients (42 ea...
Endoskopowe leczenie wybranych guzów nosa i zatok przynosowych – przydatność techniki czterech rąk
Endoscopic sinus surgery is a gold standard in chronic sinusitis since middle ’80. More and more attention is put on endosnasal tumor removal with the endoscopic technique. Two major pathologies are present in the litera...
Ocena fenotypowa pacjentów z zespołem Pendreda
Introduction. The Pendred syndrome (PS) is an autosomally recessively inherited disease. Its diagnosis requires identifi cation of the classical triad of symptoms, including hypoacusis, thyroid goitre and iodine organifi...
Udział białka RCAS1 w tworzeniu supresyjnego profilu mikrośrodowiska raka płaskonabłonkowego gardła środkowego